$BCRX
BIOCRYST PHARMACEUTICALS INC

2019 Q1 Form 10-K Financial Statement

#000117184319001727 Filed on March 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1 2017 Q4
Revenue $5.887M $3.976M $3.890M
YoY Change 48.06% -57.87% -56.7%
Cost Of Revenue $1.399M $130.0K
YoY Change -94.69%
Gross Profit $4.488M $3.976M $3.760M
YoY Change 12.88% -56.5% -42.42%
Gross Profit Margin 76.24% 100.0% 96.66%
Selling, General & Admin $6.238M $7.609M $4.700M
YoY Change -18.02% 148.82% 83.59%
% of Gross Profit 138.99% 191.37% 125.0%
Research & Development $27.49M $18.44M $16.92M
YoY Change 49.09% 9.96% 39.14%
% of Gross Profit 612.59% 463.81% 450.0%
Depreciation & Amortization $176.0K $186.0K $180.0K
YoY Change -5.38% 8.14% 5.88%
% of Gross Profit 3.92% 4.68% 4.79%
Operating Expenses $33.73M $26.05M $21.62M
YoY Change 29.49% 31.38% 46.88%
Operating Profit -$29.33M -$22.21M -$17.86M
YoY Change 32.03% 107.9% 118.07%
Interest Expense $2.726M $2.221M -$1.680M
YoY Change 22.74% 5.76% -145.53%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$31.05M -$25.78M -$19.54M
YoY Change 20.44% 81.29% 334.22%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$31.05M -$25.78M -$19.54M
YoY Change 20.47% 81.29% 334.0%
Net Earnings / Revenue -527.5% -648.31% -502.39%
Basic Earnings Per Share
Diluted Earnings Per Share -$281.8K -$261.5K -$198.3K
COMMON SHARES
Basic Shares Outstanding 110.2M
Diluted Shares Outstanding 110.2M 98.59M

Balance Sheet

Concept 2019 Q1 2018 Q1 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.6M $91.31M $114.4M
YoY Change 17.8% -7.47% 109.33%
Cash & Equivalents $34.80M $43.77M $50.28M
Short-Term Investments $72.75M $47.54M $64.12M
Other Short-Term Assets $4.500M $7.200M $4.900M
YoY Change -37.5% 56.52% 63.33%
Inventory $600.0K $7.000K
Prepaid Expenses
Receivables $5.002M $5.694M $6.117M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $117.6M $104.2M $125.4M
YoY Change 12.95% -8.23% 87.19%
LONG-TERM ASSETS
Property, Plant & Equipment $7.644M $9.395M $9.546M
YoY Change -18.64% -3.67% -3.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.70M $41.60M $41.30M
YoY Change -71.88% 994.74% 364.04%
Other Assets $5.390M $222.0K $2.027M
YoY Change 2327.93% -90.22% -46.84%
Total Long-Term Assets $24.69M $51.22M $52.87M
YoY Change -51.79% 219.88% 131.27%
TOTAL ASSETS
Total Short-Term Assets $117.6M $104.2M $125.4M
Total Long-Term Assets $24.69M $51.22M $52.87M
Total Assets $142.3M $155.4M $178.3M
YoY Change -8.39% 19.97% 98.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.935M $3.588M $6.337M
YoY Change 93.28% -33.96% 48.44%
Accrued Expenses $16.55M $15.62M $12.70M
YoY Change 5.91% 37.84% 17.19%
Deferred Revenue
YoY Change
Short-Term Debt $29.20M $28.80M $28.70M
YoY Change 1.39% 1.41% 1.77%
Long-Term Debt Due $0.00 $6.600M $6.500M
YoY Change -100.0% 407.69%
Total Short-Term Liabilities $66.33M $75.34M $74.84M
YoY Change -11.97% 28.66% 37.67%
LONG-TERM LIABILITIES
Long-Term Debt $49.60M $17.80M $19.50M
YoY Change 178.65% -26.75% -23.53%
Other Long-Term Liabilities $3.889M $100.0K $200.0K
YoY Change 3789.0% -98.77% -97.62%
Total Long-Term Liabilities $3.889M $17.90M $19.70M
YoY Change -78.27% -44.75% -41.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.33M $75.34M $74.84M
Total Long-Term Liabilities $3.889M $17.90M $19.70M
Total Liabilities $70.22M $93.30M $94.50M
YoY Change -24.74% 2.53% 7.02%
SHAREHOLDERS EQUITY
Retained Earnings -$762.8M -$630.7M -$631.8M
YoY Change 20.94% 8.69% 11.62%
Common Stock $1.103M $987.0K $984.0K
YoY Change 11.75% 22.76% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.51M $62.05M $83.77M
YoY Change
Total Liabilities & Shareholders Equity $142.3M $155.4M $178.3M
YoY Change -8.39% 19.97% 98.4%

Cashflow Statement

Concept 2019 Q1 2018 Q1 2017 Q4
OPERATING ACTIVITIES
Net Income -$31.05M -$25.78M -$19.54M
YoY Change 20.47% 81.29% 334.0%
Depreciation, Depletion And Amortization $176.0K $186.0K $180.0K
YoY Change -5.38% 8.14% 5.88%
Cash From Operating Activities -$27.00M -$19.65M -$10.52M
YoY Change 37.37% 130.48% 79.52%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$40.00K -$120.0K
YoY Change 125.0%
Acquisitions
YoY Change
Other Investing Activities $15.97M $15.96M -$55.69M
YoY Change 0.06% 23.91% 466.53%
Cash From Investing Activities $15.88M $15.93M -$55.81M
YoY Change -0.29% 12.69% 467.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.04M -1.476M 570.0K
YoY Change -1457.72% -103.03% -75.54%
NET CHANGE
Cash From Operating Activities -27.00M -19.65M -10.52M
Cash From Investing Activities 15.88M 15.93M -55.81M
Cash From Financing Activities 20.04M -1.476M 570.0K
Net Change In Cash 8.923M -5.202M -65.76M
YoY Change -271.53% -109.58% 392.22%
FREE CASH FLOW
Cash From Operating Activities -$27.00M -$19.65M -$10.52M
Capital Expenditures -$90.00K -$40.00K -$120.0K
Free Cash Flow -$26.91M -$19.61M -$10.40M
YoY Change 37.19% 130.01% 77.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 bcrx Accrued Development Costs
AccruedDevelopmentCosts
7564000
CY2017Q4 bcrx Accrued Development Costs
AccruedDevelopmentCosts
6683000
CY2018Q4 bcrx Accrued Inventory Expense
AccruedInventoryExpense
1649000
CY2017Q4 bcrx Accrued Inventory Expense
AccruedInventoryExpense
CY2018 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
110000
CY2017 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
157000
CY2016 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
523000
CY2018Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
444000
CY2017Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
412000
CY2018Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
22376000
CY2017 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-74000
CY2016 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-71000
CY2018 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
CY2017 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
564000
CY2016 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
1798000
CY2017Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
34257000
CY2018Q4 bcrx Available For Sale Securities Debt Maturities Maturing After Two Years
AvailableForSaleSecuritiesDebtMaturitiesMaturingAfterTwoYears
CY2017Q4 bcrx Available For Sale Securities Debt Maturities Maturing After Two Years
AvailableForSaleSecuritiesDebtMaturitiesMaturingAfterTwoYears
7038000
CY2018 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-143000
CY2018Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
4291000
CY2018Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
5791000
CY2018Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
7779000
CY2018Q4 bcrx Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedNextYear
10423000
CY2018 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
CY2017 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
5949000
CY2016 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
CY2018 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
2183000
CY2017 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
918000
CY2016 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
559000
CY2018 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
-76000
CY2017 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
122000
CY2016 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
329000
CY2018Q4 bcrx Lease Financing Obligation Net Of Current
LeaseFinancingObligationNetOfCurrent
2703000
CY2017Q4 bcrx Lease Financing Obligation Net Of Current
LeaseFinancingObligationNetOfCurrent
2751000
CY2017Q4 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
200000000
CY2018 bcrx Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7769000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6337000
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
110176627
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
559268095
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4293000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6117000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15891000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12699000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
118000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
729000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6095000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5327000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-243000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
780400000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
714869000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8487000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12621000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9396000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9396000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12621000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8487000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
885000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
876000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
558000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2274000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2067000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1226000
CY2018Q4 us-gaap Assets
Assets
146841000
CY2017Q4 us-gaap Assets
Assets
178259000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
114352000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
125391000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
316000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
244000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99965000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
105241000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
77736000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
64115000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100112000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
105410000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
77736000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
64115000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
22376000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
41295000
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
47000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
75000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26731000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50282000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53568000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23650000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30511000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28275000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25293000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29918000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6861000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110063000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98411000
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2297000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
114873000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
82597000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110063000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98411000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1101000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
984000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-101306000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66013000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54950000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1142000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
74960000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1126000
CY2018Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
9000
CY2017Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
210000
CY2018Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
152000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
649000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
899000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
54000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
155000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
221000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8484000
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7300000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1854000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
209109000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
183319000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
137234000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
117787000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5258000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2046000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
59509000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
55208000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7108000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
208460000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6424000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
182420000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
418000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
421000
CY2018Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
231000
CY2017Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
478000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
724000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
664000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
504000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
770000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
704000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
483000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.98
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4659000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2905000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28284000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-7000
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
12000
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-17000
CY2018 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-108000
CY2017 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-821000
CY2016 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-843000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q4 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
73474000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
26040000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-42625000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
19838000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-29000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
71155000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1080000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21263000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-23024000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19300000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
503000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
910000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1057000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
18000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1639000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
822000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2547000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1611000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1173000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4905000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1977000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4681000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4487000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3842000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10524000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7079000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1722000
CY2016 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1631000
CY2018 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-1049000
CY2017 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-966000
CY2016 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
811000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-247000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3105000
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2244000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1649000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-500000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1112000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1009000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-877000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3702000
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1824000
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2651000
CY2016 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2525000
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
2252000
CY2017 us-gaap Interest And Other Income
InterestAndOtherIncome
1015000
CY2016 us-gaap Interest And Other Income
InterestAndOtherIncome
793000
CY2018 us-gaap Interest Expense
InterestExpense
9176000
CY2017 us-gaap Interest Expense
InterestExpense
8565000
CY2016 us-gaap Interest Expense
InterestExpense
6487000
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
9176000
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
8565000
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
6487000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
11848000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12095000
CY2018Q4 us-gaap Inventory Net
InventoryNet
1649000
CY2017Q4 us-gaap Inventory Net
InventoryNet
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
146841000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178259000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69477000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
74836000
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
25372000
CY2017Q4 us-gaap Line Of Credit
LineOfCredit
16750000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4580000
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6464000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
30000000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5000000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1000000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
12000000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12000000
CY2018 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62504000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
135703000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23304000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4768000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64642000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
29121000
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
28682000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-94220000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-57411000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-48607000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5247000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1300000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
503000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23273000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92565000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41143000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53438000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-55144000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-65782000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-101252000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-25777000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-18446000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-29597000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-27432000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-14219000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-16886000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-15134000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-19543000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
491000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
524000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
934000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1495000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
758000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
617000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
721000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1850000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2234000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
978000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2027000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
194000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-231000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-54000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-231000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
194000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
62614000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
107787000
CY2016 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
14106000
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
366000
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
328000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5277000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
1000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2390000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1381000
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47750000
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86250000
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53400000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53400000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134000000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10353000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
22658000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
67748000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
43461000
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
42652000
CY2018 us-gaap Proceeds From Sale Of Furniture And Fixtures
ProceedsFromSaleOfFurnitureAndFixtures
CY2017 us-gaap Proceeds From Sale Of Furniture And Fixtures
ProceedsFromSaleOfFurnitureAndFixtures
12000
CY2016 us-gaap Proceeds From Sale Of Furniture And Fixtures
ProceedsFromSaleOfFurnitureAndFixtures
4000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2852000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1581000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
317000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15230000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14873000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9135000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9546000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4293000
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
6117000
CY2018 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
2000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4025000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2016 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84888000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66962000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61008000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1544000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3286000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-731969000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-631843000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-630717000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20653000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25186000
CY2016 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26353000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3976000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12494000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1454000
CY2018Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2729000
CY2017Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9437000
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3099000
CY2017Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8760000
CY2017Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3890000
CY2018 us-gaap Royalty Expense
RoyaltyExpense
471000
CY2017 us-gaap Royalty Expense
RoyaltyExpense
560000
CY2016 us-gaap Royalty Expense
RoyaltyExpense
402000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29514000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13933000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11253000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
9396000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
12621000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
8487000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
114000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4272000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.92
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1578000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
83767000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
49235000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
15928000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.43
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
8196000
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
17491000
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22891000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
7202000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
9295000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
4.12
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.56
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.78
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2065000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.33
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.16
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
6.49
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y
CY2017Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.50
CY2017Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.15
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.50
CY2017Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6061000
CY2017Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17864000
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10455000
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
329000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
345000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
351000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134000000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53400000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-12000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1236000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2501000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
47724000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4750000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4255000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
51000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
148000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5976000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1226000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
495000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0 0pt 11.5pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0 0pt 11.5pt">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 27pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 27pt; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to the valuation of stock options, and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> readily apparent from other sources. Actual results could differ from those estimates.&nbsp;&nbsp;</div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103185000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84451000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73699000

Files In Submission

Name View Source Status
0001171843-19-001727-index-headers.html Edgar Link pending
0001171843-19-001727-index.html Edgar Link pending
0001171843-19-001727.txt Edgar Link pending
0001171843-19-001727-xbrl.zip Edgar Link pending
bcrx-20181231.xml Edgar Link completed
bcrx-20181231.xsd Edgar Link pending
bcrx-20181231_cal.xml Edgar Link unprocessable
bcrx-20181231_def.xml Edgar Link unprocessable
bcrx-20181231_lab.xml Edgar Link unprocessable
bcrx-20181231_pre.xml Edgar Link unprocessable
exh_21.htm Edgar Link pending
exh_23.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10k_031219p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graph.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending